MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Feb 2, 2026 · Dandekar Atul sold 7,500 shares at $44.27/share ($332.0K); exercised options for 7,500 shares

Dandekar Atul sold 7,500 shares at $44.27/share ($332.0K); exercised options for 7,500 shares

xslF345X05/form4-02022026_090232.xml

xslF345X05/form4-02022026_090232.xmlSEC.gov

Graphics and non-inline formats (not embedded below).